These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6580660)

  • 21. A study of serum prolactin levels in schizophrenia: comparison of males and females.
    Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total and free plasma neuroleptic levels in schizophrenic patients.
    Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
    Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The response of prolactin to chlorpromazine stimulation in men with hypogonadotrophic hypogonadism and early pubertal boys: relationship to sex steroid exposure.
    Winters SJ; Johnsonbaugh RE; Sherins RJ
    Clin Endocrinol (Oxf); 1982 Apr; 16(4):321-30. PubMed ID: 6807580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of chlorpromazine in serum by radioreceptor assay and HPLC.
    Krska J; Addison GM; Soni SD
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():340-5. PubMed ID: 3789642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients.
    Otani K; Kondo T; Kaneko S; Ishida M; Fukushima Y
    Int Clin Psychopharmacol; 1994; 9(4):287-9. PubMed ID: 7868851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in therapeutic blood monitoring of chlorpromazine.
    Rivera-Calimlim L
    Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
    Schizophr Res; 2013 Apr; 145(1-3):116-9. PubMed ID: 23375624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
    Konarzewska B; Galińska-Skok B; Waszkiewicz N; Łazarczyk-Kirejczyk J; Malus A; Simonienko K; Szulc A
    Neuro Endocrinol Lett; 2014; 35(1):50-7. PubMed ID: 24625910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients.
    Martinos A; Rinieris P; Papachristou DN; Souvatzoglou A; Koutras DA; Stefanis C
    Neuropsychobiology; 1986; 16(2-3):72-7. PubMed ID: 3108695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.